Exome Asset Management »

Pliant Therapeutics shares owned by Exome Asset Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by Exome Asset Management from 13F filings

Historical chart of Exome Asset Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by Exome Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by Exome Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $898k 50k 18.11

More positions owned by Exome Asset Management

Dr Reddys Labs Adr (RDY)
Eli Lilly & Co. (LLY)
ImmunoGen
Cigna Corp (CI)
Celldex Therapeutics Com New (CLDX)
Tg Therapeutics (TGTX)
Rhythm Pharmaceuticals (RYTM)
Alpine Immune Sciences (ALPN)
Dex (DXCM)
Madrigal Pharmaceuticals (MDGL)
Cytokinetics Com New (CYTK)
Inhibrx (INBX)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Bridgebio Pharma (BBIO)

View all positions for Exome Asset Management

Top funds holding Pliant Therapeutics

T. Rowe Price Associates
First Light Asset Management
Laurion Capital Management
Vanguard Group
Blue Owl Capital Holdings
Redmile Group
Trv Gp Iv
Dr. Jeffrey R. Jay, M.D.
Citadel Advisors
Franklin Resources
Casdin Capital
RA Capital Management
Deutsche Bank Aktiengesellschaft
Bessemer
Candriam Luxembourg S.C.A.

View all funds holding Pliant Therapeutics